NEW YORK (GenomeWeb News) – South Korean firm Panagene today said that it has signed an agreement to provide Dako with Peptide Nucleic Acid probes for use in diagnostic or research products.

PNA is an artificially synthesized DNA analogue that Panagene said has higher binding affinity, specificity, and sensitivity to a target, as well as high biological/chemical stability. Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.